OCTP Oxford Cannabinoid Technologies Holdings Plc

TIDMOCTP

RNS Number : 2585G

Oxford Cannabinoid Tech.Holdings

17 July 2023

17 July 2023

Oxford Cannabinoid Technologies Holdings plc

PDMR and Director Dealings

Oxford Cannabinoid Technologies Holdings plc ("the Company"), announces that it has been informed today that Clarissa Sowemimo-Coker, Chief Executive Officer and Robin Bennett, General Counsel and Company Secretary have today purchased ordinary shares of GBP0.01 in the Company ("Ordinary Shares").

 
 Director/PDMR              Total number of    Price per         Number of Ordinary 
                             Ordinary Shares    Ordinary Share    Shares held following 
                             purchased                            the purchase 
 Clarissa Sowemimo-Coker    310,406            GBP0.009064       1,500,000 
                           -----------------  ----------------  ----------------------- 
 Robin Bennett              331,012            GBP0.009          331,012 
                           -----------------  ----------------  ----------------------- 
 

The PDMR forms are set out below.

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014 (which forms part of domestic UK law pursuant to the European Union (Withdrawal) Act 2018).

The Directors of the Company accept responsibility for the content of this announcement.

Enquiries:

 
 Oxford Cannabinoid Technologies    +44 (0)20 3034 2820 
  Holdings plc                       clarissa@oxcantech.com 
  Clarissa Sowemimo-Coker (CEO) 
 Cairn Financial Advisers LLP 
  Emily Staples                       +44 (0)20 7213 0897 
  Jo Turner                           +44 (0) 20 7213 0885 
 Axis Capital Markets Limited 
  Richard Hutchison                   +44 (0)20 3026 0320 
 
 
  Walbrook PR Limited 
  Paul Vann/Nick Rome/Joe Walker      +44 (0)20 7933 8780 
                                      +44 (0)7768 807631 
                                      oxcantech@walbrookpr.com 
 

About Oxford Cannabinoid Technologies Holdings Plc:

Oxford Cannabinoid Technologies Holdings plc ("OCTP") is the holding company of Oxford Cannabinoid Technologies Ltd (together the "Group"), a pharmaceutical Group developing prescription cannabinoid medicines targeting the U$ multi-billion global pain market.

OCTP currently has a portfolio of four drug development programmes. Its lead compound, OCT461201, will initially target neuropathic and visceral pain (including irritable bowel syndrome ("IBS") and chemotherapy induced peripheral neuropathy ("CIPN")), with the Phase I clinical trial, aimed at demonstrating safety and tolerability. Trial results are expected in Q3 2023. The global market for CIPN alone is currently valued at US$1.61bn and is forecast to reach US$2.37bn by the year 2027.

OCTP's drug development pipeline comprises both natural and synthetic compounds, and includes compounds targeting trigeminal neuralgia, a severe type of face pain, and cannabinoid derivatives targeting pain and potentially other therapeutic areas. Having established an exclusive license agreement with Canopy Growth Corporation for their entire pharmaceutical cannabinoid derivative library, OCTP now has a portfolio of almost five hundred derivatives and intellectual property rights including fourteen patent families and associated research data.

OCTP has a clearly defined path to commercialisation, revenues and growth. The Group is developing drug candidates through clinical trials to gain regulatory approval (FDA/MHRA/EMA) that will enable medical professionals to prescribe them with confidence. OCTP's portfolio aims to balance risk, value and time to market, whilst ensuring market exclusivity around all its key activities.

 
 Notification of a Transaction pursuant to Article 19(1) of Regulation 
  (EU) No. 596/2014 
 1     Details of the person discharging managerial responsibilities/person 
        closely associated 
----  ------------------------------------------------------------------------------------ 
 a.    Name                         Clarissa Sowemimo-Coker 
                                   ------------------------------------------------------- 
 2     Reason for notification 
      ---------------------------  ------------------------------------------------------- 
 a.    Position/Status              Chief Executive Officer 
      ---------------------------  ------------------------------------------------------- 
 b.    Initial notification/        Initial notification 
        Amendment 
      ---------------------------  ------------------------------------------------------- 
 3     Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
      ------------------------------------------------------------------------------------ 
 a.    Name                         Oxford Cannabinoid Technologies Holdings 
                                     plc 
      --------------------------- 
 b.    LEI 
                                                    2138005SRWT4998BCE35 
      ---------------------------  ------------------------------------------------------- 
 4     Details of the transaction(s): section to be repeated for 
        (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transactions have 
        been conducted 
      ------------------------------------------------------------------------------------ 
 a.    Description of 
        the financial                 Ordinary shares of GBP0.01 each 
        instrument, type 
        of instrument                 GB00BMVMRB86 
 
        Identification 
        Code 
      ---------------------------  ------------------------------------------------------- 
 b.    Nature of the                Acquisition of ordinary shares of GBP0.01 
        transaction                  each 
      ---------------------------  ------------------------------------------------------- 
 
 c.    Price(s) and volume(s)            Price(s)       Volume(s) 
      ---------------------------       ------------- 
    GBP0.009064                                         310,406 
   --------------------------------------------------  ----------- 
 
 d.    Aggregated information       N/A - single transaction 
 
        - Aggregated Volume 
 
        - Price 
      ---------------------------  ------------------------------------------------------- 
 e.    Date of the transaction      17 July 2023 
      ---------------------------  ------------------------------------------------------- 
 f.    Place of the transaction     London, UK 
      ---------------------------  ------------------------------------------------------- 
 
 
 
 Notification of a Transaction pursuant to Article 19(1) of Regulation 
  (EU) No. 596/2014 
 1      Details of the person discharging managerial responsibilities/person 
         closely associated 
-----  ------------------------------------------------------------------------------------ 
 a.     Name                         Robin Bennett 
                                    ------------------------------------------------------- 
 2      Reason for notification 
       ---------------------------  ------------------------------------------------------- 
 a.     Position/Status              General Counsel and Company Secretary 
       ---------------------------  ------------------------------------------------------- 
 b.     Initial notification/        Initial notification 
         Amendment 
       ---------------------------  ------------------------------------------------------- 
 3      Details of the issuer, emission allowance market participant, 
         auction platform, auctioneer or auction monitor 
       ------------------------------------------------------------------------------------ 
 a.     Name                         Oxford Cannabinoid Technologies Holdings 
                                      plc 
       --------------------------- 
 b.     LEI 
                                                     2138005SRWT4998BCE35 
       ---------------------------  ------------------------------------------------------- 
 4      Details of the transaction(s): section to be repeated for 
         (i) each type of instrument; (ii) each type of transaction; 
         (iii) each date; and (iv) each place where transactions have 
         been conducted 
       ------------------------------------------------------------------------------------ 
 a.     Description of 
         the financial                 Ordinary shares of GBP0.01 each 
         instrument, type 
         of instrument                 GB00BMVMRB86 
 
         Identification 
         Code 
       ---------------------------  ------------------------------------------------------- 
 b.     Nature of the                Acquisition of ordinary shares of GBP0.01 
         transaction                  each 
       ---------------------------  ------------------------------------------------------- 
 
 c.     Price(s) and volume(s)             Price(s)      Volume(s) 
       ---------------------------        ------------ 
    GBP0.009                                             331,012 
   ---------------------------------------------------  ----------- 
 
 
 d.     Aggregated information       N/A - single transaction 
 
         - Aggregated Volume 
 
         - Price 
       ---------------------------  ------------------------------------------------------- 
 e.     Date of the transaction      17 July 2023 
       ---------------------------  ------------------------------------------------------- 
 
 

, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHMZGMNZNDGFZM

(END) Dow Jones Newswires

July 17, 2023 08:16 ET (12:16 GMT)